eClinical Tech News

Firefly Neuroscience highlighted two studies demonstrating the potential of its FDA-cleared Brain Network Analytics (BNA™) platform in drug development...

Pluri Inc. secured a $6.5 million private investment from Alejandro Weinstein, who will join the company’s board. Simultaneously, Pluri...

Tiziana Life Sciences announced positive preclinical results for their intranasal anti-CD3 monoclonal antibody, foralumab, in treating traumatic spinal cord...

Outlook Therapeutics presented 12-week data from its NORSE EIGHT clinical trial of ONS-5010 (bevacizumab-vikg) for wet age-related macular degeneration...

AIM ImmunoTech Inc. announced final clinical study results (AMP-518) for Ampligen in treating post-COVID conditions, specifically fatigue. The study,...

Anthos Therapeutics announced the publication of positive results from its AZALEA-TIMI 71 study in the •New England Journal of...

Tiziana Life SciencesLife Sciences has discovered new immune biomarkers in patients with non-active secondary progressive multiple sclerosis (na-SPMS) treated...

Cullgen Inc., a clinical-stage biopharmaceutical company, has initiated human trials for CG001419, a potential first-in-class, oral, pan-TRK protein degrader...

Lisata Therapeutics announced preliminary data from Cohort A of its Phase 2 ASCEND trial evaluating certepetide, combined with standard...

Coherus BioSciences announced final data from its Phase 2 trial of casdozokitug (casdozo), an IL-27-targeting antibody, combined with atezolizumab...